Dietary arginine alters time of symptom onset in Huntington's disease transgenic mice

被引:30
作者
Deckel, AW
Volmer, P
Weiner, R
Gary, KA
Covault, J
Sasso, D
Schmerler, N
Watts, D
Yan, Z
Abeles, I
机构
[1] Univ Connecticut, Ctr Hlth, Dept Psychiat, Farmington, CT 06030 USA
[2] Univ Connecticut, Ctr Hlth, Dept Diagnost Imaging & Therapeut, Farmington, CT 06030 USA
[3] Univ Connecticut, Ctr Hlth, Program Neurosci, Farmington, CT 06030 USA
[4] Univ Connecticut, Ctr Hlth, Hartford Hosp, Huntingtons Dis Program, Hartford, CT 06102 USA
关键词
Huntington's disease; L-arginine; nitric oxide; peroxynitrite; neurodegeneration; cerebral blood flow; diet;
D O I
10.1016/S0006-8993(00)02640-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent neuroimaging studies reported complex changes in cerebral blood how (CBF) in early-staged Huntington's disease (HD) patients. Deckel and co-workers [Deckel and Duffy, Brain Res. (in press); Deckel and Cohen, Frog. Neuro-Psychopharmacol. Biol. Psychiatry 24 (2000) 193; Deckel et al., Neurology 51 (1998) 1576; Deckel et al., J. Nucl. Med. 41 (2000) 773] suggested that these findings might be accounted for, in part, by alterations in cerebral nitric oxide (NO) and its byproduct, peroxynitrite. The current experiment tested this hypothesis by altering NO levels via manipulations of dietary L-arginine (ARG), the dietary precursor of NO, in mice transgenic for HD. Seventy-one mice were assigned at 12 weeks of age to one of three isocaloric diets that varied in their content of ARG. These diets included: (a) 0% ARG, (b) 1.2% ARG (i.e. typical mouse chow), or (c) 5% ARG. The 5% ARG diets in HD mice accelerated the time of onset of body weight loss (P<0.05) and motor impairments (P<0.05), and increased resting CBF in HD relative to control (P<0.05). Conversely, the 0% ARG diet demonstrated no loss of body weight and had no changes in CBF relative to controls. However, the 0% ARG HD group continued to show significant deficits on motor testing (P<0.05). The 1.2% ARG HD group showed reduced body weight loss, better motor functioning, and fewer changes in CBF compared to the 5% ARG HD group. Immunocytochemistry analysis found greater deposition of nitrotyrosine in the cortex, and vasculature, of HD+ mice, 58 and 1.2%>0% arginine diets. When collapsed across all conditions, CBF inversely correlated (P<0.05) both with the body weight and motor changes suggesting that changes in CBF are associated with behavioral decline in HD mice. Collectively, these findings indicate that dietary consumption of the NO precursor ARG has a measurable, but complex, effect on symptom progression in HD transgenic mice, and implicates NO in the pathophysiology of HD. (C) 2000 Elsevier Science BN. All rights reserved.
引用
收藏
页码:187 / 195
页数:9
相关论文
共 77 条
[1]   Increased endothelium-monocyte interactions in salt-sensitive hypertension: Effect of L-arginine [J].
Artigues, C ;
Richard, V ;
Roussel, C ;
Lallemand, F ;
Henry, JP ;
Thuillez, C .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (03) :468-473
[2]   Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin [J].
Bao, J ;
Sharp, AH ;
Wagster, MV ;
Becher, M ;
Schilling, G ;
Ross, CA ;
Dawson, VL ;
Dawson, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (10) :5037-5042
[3]   DOES IMPAIRMENT OF ENERGY-METABOLISM RESULT IN EXCITOTOXIC NEURONAL DEATH IN NEURODEGENERATIVE ILLNESSES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1992, 31 (02) :119-130
[4]   METABOLIC CONSEQUENCES OF DNA DAMAGE - DNA DAMAGE INDUCED ALTERATIONS IN GLUCOSE-METABOLISM BY ACTIVATION OF POLY(ADP-RIBOSE) POLYMERASE [J].
BERGER, SJ ;
SUDAR, DC ;
BERGER, NA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 134 (01) :227-232
[5]   Dietary L-arginine and α-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms [J].
Böger, RH ;
Böde-Boger, SM ;
Phivthong-ngam, L ;
Brandes, RP ;
Schwedhelm, E ;
Mügge, A ;
Böhme, M ;
Tsikas, D ;
Frölich, JC .
ATHEROSCLEROSIS, 1998, 141 (01) :31-43
[6]  
Bredt David S., 1995, P1, DOI 10.1016/B978-012721985-1/50003-4
[7]   ISOLATION OF NITRIC-OXIDE SYNTHETASE, A CALMODULIN-REQUIRING ENZYME [J].
BREDT, DS ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) :682-685
[8]  
Carter RJ, 1999, J NEUROSCI, V19, P3248
[9]   Nitric oxide synthases:: targets for therapeutic strategies in neurological diseases [J].
Chabrier, PE ;
Demerlé-Pallardy, C ;
Auguet, M .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (8-9) :1029-1035
[10]  
Clark V. P., 1999, Society for Neuroscience Abstracts, V25, P831